Medical research

A new therapeutic target against the most common lung cancer

TIMP-1 protein levels in both tissues and blood have been repeatedly associated with a poor prognosis in lung cancers, but its role has been unknown. Now, a study led by Jordi Alcaraz, lecturer at the Faculty of Medicine ...

Medications

Can aspirin help tackle some cancers?

Low-dose aspirin may improve survival odds for patients battling head/neck and lung cancer, two new studies suggest.

Oncology & Cancer

New biomarker identified for early diagnosis of lung cancer

High levels of cytoskeleton-associated protein 4 (CKAP4) have been identified in the blood of patients with lung cancer. In a novel study in The American Journal of Pathology investigators found that CKAP4 levels were significantly ...

Oncology & Cancer

New method for suppressing lung cancer oncogene

Researchers at Okayama University describe in Oncotarget an approach for suppressing the expression of the SOX2 protein, an oncogene associated with both lung and esophageal cancer. The procedure, based on the targeted delivery ...

Oncology & Cancer

Hope for better lung cancer treatment on horizon

A Melbourne study is set to improve treatment options for patients with the second most common type of lung cancer, lung squamous cell carcinoma, a disease for which new anti-cancer drugs are urgently needed.

Oncology & Cancer

New study proves one lung cancer subtype can switch to another

A new study co-authored by a researcher starting her laboratory at the University of Kentucky Markey Cancer Center shows that in certain genetic situations, one non-small cell lung cancer subtype can change into another subtype.

Oncology & Cancer

Study shows that antioxidants may reduce lung cancer risk

An epidemiological study published in Frontiers in Oncology suggests that a diet high in carotenoids and vitamin C may protect against lung cancer. The study authors found that vitamin C appears to reduce the risk of lung ...

page 3 from 6